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A best evidence topic in surgery was written according to a structured protocol. The question addressed
how subintimal angioplasty (SIA) compares to transluminal angioplasty (TA) for the treatment of femoral
occlusive disease. One hundred and thirty two papers were found using the reported search; the 5 which
represented the best evidence to answer the question are discussed. The evidence on this subject is
limited; there are no randomised controlled trials (RCTs) comparing SIA to TA for pathologically equiv-
alent lesions. However SIA remains a safe and effective alternative to surgical bypass grafting when TA
cannot be performed.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
A best evidence topic was constructed according to a structured
protocol, as described in the International Journal of Surgery [1]
Table 1.
2. Clinical scenario
A patient with high operative risk presents with femoral artery
occlusive disease. Active treatment is indicated. Two interventional
approaches are available which you feel should be considered in
this case, however you are unsure which, subintimal angioplasty
(SIA) or transluminal angioplasty (TA), will give better results in
terms of safety, patency and outcome. You resolve to consult the
literature to ﬁnd outcomes data on each procedure.
3. Three part question
In patients receiving active treatment for femoral artery occlu-
sive disease, does SIA or TA provide better results, in terms of
patency, outcome and safety?tudy; SR, systematic review;
sty; TA, transluminal angio-
, Transatlantic Inter-Society
; fax: þ44 (0) 1603 286428.
lop).
ciates Ltd. Published by Elsevier Lt4. Search strategy
A search strategy was constructed using Medline and the
PubMed interface: (subintimal AND angioplasty OR transluminal
AND angioplasty; AND femoral AND occlusive AND disease) to
identify articles published between from 1948 and February 2013.
The search was duplicate ﬁltered. Reference lists of key articles
were also searched for further references.
5. Search outcome
A total of 132 papers were identiﬁed using the reported PubMed
search. Of these 62 did not answer the research questions directly,
27 were not in English language, 22 were unrelated, 6 were solely
concerned with technical aspects of the procedure, 5 were dupli-
cations, 4 were concerned with medical management, 4 were basic
science articles, and 2were unrelated case reports. Five represented
the best evidence to answer the clinical question.
6. Discussion
Femoral artery occlusive disease represents an increasing
healthcare burden. Bypass grafting remains the preferred route for
reperfusion, but entails signiﬁcant operative morbidity and mor-
tality. Minimally invasive techniques have a role in the manage-
ment of patients presenting with femoral artery occlusive disease
who are un-suitable for open surgery. Two minimally invasived. All rights reserved.
Table 1
Best evidence papers.
Author, date and country Patient group Study type and
level of evidence
Outcomes Key result Comments
Bolia et al. 1994
Leicester UK [2]
24 limbs in 21 patients were
treated by SIA (10) or TA (19)
Retrospective
case series.
Level 4 evidence
Technical success (%) 100% This early case series demonstrated SIA to be a safe
and effective procedure. However failure to differentiate
between outcomes achieved between SIA and TA limits the
application of the authors conclusions to the current review.
TA N/A
SIA N/A
Antusevas et al. 2008,
Kaunas, Lithuania [3].
73 SIA and 75 TA were
performed in 146
patients between
June 2002 and August 2006.
Prospective
observational study.
Evidence level 4.
Initial technical success (%) This was a well conducted prospective study. The authors reported
16 minor complications furthermore conversion to bypass operation
was required in 7 cases due to inability to perform SIA. The authors
did not identify any peri-operative risk factors to be
associated with worse long term outcome.
SIA 64 (87.7)
TA 61 (81.3)
Primary patencies
at 1, 6, 12, 24
months (%) (P value)
<0.001
SIA
1 84.9  4.2
6 71.2  5.1
12 68.5  5.3
24 65.8  5.2
TA
1 81.3  4.4
6 45.3  5.7
12 42.7  5.6
24 38.7  5.5
Mean pre-procedure ABPI (SD)
SIA 0.34  0.14
TA 0.35  0.12
Mean post-procedure ABPI (SD)
SIA 09  0.2
TA 0.87  0.23
Kim et al. 2010 Tokyo Japan [4] 54 patients (63 limbs)
with TASC-C or
D limb ischemia
underwent SIA between
April 2006 and June 2008.
Retrospective
case series.
Level 4 evidence
Technical success (%) 59 (93.6) This study was a retrospective case series describing the
experience with SIA at a single institution, performed by a single team.
This study was limited by its retrospective nature. Patients were selected
for SIA due to their unsuitability for open surgery.
The authors note that the high 12-month re-occlusion rate was a reﬂection of
patient characteristics, 79.4% of cases were classiﬁed as TASC-D. The authors
identiﬁed occlusion length, distal SFA involvement and distal run-off to be
signiﬁcantly associated with 12-month re-occlusion.
Patency at 12-months 33 (51.3)
Major complications (%) 0 (0)
Minor complications (%) 3 [5]
Mean pre-procedure ABPI (SD) 0.43  0.25
Mean post-procedure ABPI (SD) 0.89  0.16
Re-intervention rate (%)
Repeat SIA 12 (19)
Bypass surgery 10 (15.8)
Below knee amputation 9 (14.3)
Met et al. 2008, Amsterdam,
The Netherlands [5].
23 articles relating to SIA were
identiﬁed published
between 1994 and 2006.
Systematic review
of cohort studies.
Evidence level 2a.
Initial technical success (%) 80e90 Met et al. performed a systematic review of publications relating to SIA. They
identiﬁed 23 publications which appeared to indicate that SIA is safe and
effective alternative to bypass surgery and could be used a temporary
measure or ‘bypass sparing’ procedure.
Clinical success (resolution
of symptoms at 1-year, %)
50e70
Primary patencies at 1-year (%) 50
Complication rates (%) 8e17
Markose et al. 2010,
Leicester UK [6]
13 reports relating
to SIA published
between 2004 and 2009.
Systematic review
of cohort studies,
reviews and
prospective and
retrospective case
series. Evidence level 2a.
Initial technical success (%) 99.5e83 Markose et al. performed a systematic review of publications relating to.
They identiﬁed numerous studies 13 of which were related to SIA.
Their results indicate that SIA is a safe and effective procedure. However
failure of included trials to directly compare SIA to TA when both procedures
could be performed limits the applicability of these results to the current
study question.
Primary patencies at 1-year (%) 70e50
Primary patencies at 2-years 61e53
Complication rates (%) 6.2e17
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BEST EVIDENCE TOPICtechniques are currently employed; TA and SIA. TA involves passing
a balloon catheter, under radiological guidance, through the
occluded segment of the true arterial lumen followed by expansion,
re-canalisation stenting. In contrast SIA involves inserting a guide
wire, followed by a balloon catheter into a sub-intimal dissection
plane, re-entering the true lumen distally, followed by balloon
expansion and stent placement to create a neo-lumen. There is
currently limited evidence to determine which technique, TA or
SIA, should be adopted as ‘best practice’.
In a 1994 retrospective case series Bolia et al. [2] described 29
cases of occluded crural arteries (in 24 limbs), 10 of which were
treated using SIA and 19 TA. Measured outcomes included: initial
technical success, early re-occlusion, major and minor complica-
tions, recurrence of symptoms and pre/post procedure ABPI. Initial
technical success was achieved in 9/10 (90%) patients undergoing
SIA and 16/19 (84%) undergoing TA. There was one early re-
occlusion (at 3 days) and two limbs re-developed symptoms 3
and 4 months after the procedure. Median ABPIs improved from
0.36 (range 0e0.68) pre-procedure to 0.86 (range 0e1) post-
procedure. Two patients suffered major complications and two
suffered minor complications (groin haematoma). This small case
series demonstrated that both SIA and TA are effective approaches
for treatment of occluded crural arteries. However it was limited by
its failure to compare techniques for all outcome measures
described and failure describe how patients were selected for
either TA or SIA.
In a 2008 prospective observational study Antusevas et al. [3]
described 73 SIAs and 75 TAs in 146 patients performed between
March 2004 and April 2006 at a single centre in Lithuania. Initial
success was achieved in 64 (87.7%) of those treated with SIA and 61
(81.3%) of those treated with TA. Primary patencies at 1, 6, 12, 24
months were respectively 84.9  4.2, 71.2  5.1, 68.5  5.3 and
65.8  5.2 for SIA and 81.3  4.4, 45.3  5.7, 42.7  5.6 and
38.7  5.5 for TA which was statistically signiﬁcant (P < 0.001, log
rank (Mantel and Cox) test). Mean ABPI improved in both groups,
SIA 0.34  0.14 to 09  0.2 and TA 0.35  0.12 to 0.87  0.23;
however this was not statistically signiﬁcant. This was a well con-
ducted prospective observational study. The study was limited by a
number of factors including small sample size and lack of ran-
domisation. Furthermore the treatment groups were noted to differ
in initial severity of the lesions with the SIA group having signiﬁ-
cantly longer occlusions (12 5.57 cm vs 6.3 3.56 cm, P< 0.05) at
baseline, potentially biasing the results. However as noted the SIA
group had better primary patencies, therefore this ﬁnding perhaps
strengthens the conclusion of SIA superiority which the authors
regard as the treatment of choice in those unsuitable for open
procedures at their institution.
In a 2010 retrospective case series, Kim et al. [4] reported out-
comes and analysed factors associated with re-occlusion at 12-
months in 53 patients (63 limbs) treated with SIA at a single
institution in Japan between April 2006 and June 2008. Technical
success was achieved in 59 (93.6%) limbs. There were no major and
few minor (5%) complications. These included ﬂow limiting
dissection and haematoma formation at the vessel entry site.
Despite initial technical success at 12-months only 33 (51.7%) of
arteries remained patent. This necessitated re-intervention with
SIA in 12 (19%), surgical bypass in 10 (15.8%) and below knee
amputation (BKA) in 9 (14.3%). The authors attributed the poor 12-
month patency rates to the initially poor characteristics of the le-
sions treated, 79.4% of which were classiﬁed as Transatlantic Inter-
Society Consensus-D (TASC-D). Occlusion length, distal superﬁcial
femoral artery (SFA) involvement and distal run off were found to
be signiﬁcantly associated with 12-month re-occlusion on univar-
iate analysis (P ¼ 0.040, 0.006, 0.018, respectively). This study was
limited by its retrospective nature and lack of robustrandomisation. Patients were selected to undergo SIA on the basis
of their unsuitability to undergo bypass surgery in the ﬁrst instance.
As these patients were classiﬁed as TASC-D endovascular therapy
was likely to be challenging.
In 2008 Met et al. [5] performed a systematic review of publi-
cations relating to SIA. Twenty three publications indicated that SIA
is safe and effective alternative to bypass surgery and could be used
a temporary measure or ‘bypass sparing’ procedure. Pooled initial
technical successes of between 80 and 90% were identiﬁed which
appeared to drop off rapidly at one year to 50%. However clinical
success at 1-year (as deﬁned by resolution of symptoms) remained
higher in some reports with pooled clinical success rates of 50e
70%. Complication rates across all studies were low with pooled
complication rates between 8 and 17%.
In 2010 Markose et al. [6] performed a systematic review of 13
reports describing SIA. Of these only one, Antusevas et al. [3],
compared SIA to TA. The remaining studies considered SIA alone or
in relation to bypass grafting or medical management. Initial
technical success of SIA ranged from 99.5% to 83% with primary
patencies at 1 year ranging from 70% to 50% and 61% to 53% at 2
years. However some centres had achieved superior results e.g.
72.8% primary patency at 5 years. The authors conclude that SIA is a
valuable, safe and effective technique. However the application of
this report to the study question is limited by the small number of
studies comparing SIA to TA.
7. Clinical bottom line
The technique of SIAwas originally described as a ‘complication’
of TA [7]. Thus almost by deﬁnition SIA can be performed in situ-
ations where TA cannot. This has biased the literature towards SIA
being performed in clinical situations of more severe disease.
Furthermore this has resulted in few reports directly comparing the
techniques, with those that were identiﬁed failing to randomise
patients. There is no doubt that SIA offers a safe and effective
alternative when TA cannot be performed. However the question
SIA vs TA superiority for the outcomes discussed remains for pa-
tients with lesions amenable to both techniques. There is a current
need for prospective randomised trials comparing SIA to TA in pa-
tients with similar lesions. SIA remains a viable treatment option
for those unable to undergo bypass grafting or PTA but it’s status
compared to PTA for treating pathologically equivalent lesions
continues to be unknown.
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